Top virologists sound the alarm on bird flu and plead with world leaders to prepare for another pandemic
Leading virologists from over 40 countries are sounding the alarm over the increasing threat of H5N1 avian flu—which can cause coughing, body aches, fatigue, pneumonia, and other symptoms in humans—urging global leaders to step up with a range of measures and to use knowledge gained during the COVID pandemic.
'In the U.S. sporadic human infections with no known contact with infected animals highlight the possibility of viral adaptation for efficient human-to-human transmission,' Global Virus Network (GVN) scientists write in a commentary published this week in The Lancet Regional Health–Americas. 'Concurrently, the virus continues to circulate in wild birds, backyard flocks, and hunted migratory species, further amplifying the risk to humans and domestic animals.'
The experts compel leaders to address the issue by boosting surveillance, enhancing biosecurity, and preparing for potential human-to-human viral transmission.
The authors note that more than 995 dairy cow herds and at least 70 people have been infected with H5N1, including severe cases and the first reported U.S. death.
'Understanding the current landscape of H5N1 infections is critical for effective prevention and response,' Dr. Sten H. Vermund, chief medical officer of the GVN and dean of the USF Health College of Public Health at the University of South Florida, said in a press release. 'The virus's ability to infect both animals and humans, combined with recent genetic changes, underscores the importance of proactive surveillance and rapid response measures.'
The highly pathogenic influenza virus is now circulating in all 50 states and Canada, the virologists warn, resulting in the loss or culling of more than 168 million poultry animals in the U.S. since 2022. While human-to-human transmission is not documented, experts warn that virus mutations or the combination of two flu viruses could increase transmissibility.
The researchers made several recommendations:
Continuously monitoring animals, including testing milk, wastewater, and people working with infected animals, to track virus evolution that may lead to human-to human transmissibility.
Accelerating the sharing of genomic data among global research networks to track virus evolution and spread.
Using personal protective equipment and strict farm-cleaning protocols.
Advocating for self-administered diagnostic tests for farmworkers and health care access for frontline medical workers.
Providing more funding for responses, especially in high-risk regions.
Investing in predicting traits of avian flu viruses from genetic data.
Developing and rapidly administering vaccines to people and animals.
Conducting clinical studies on the properties of emerging virus strains, potential therapies, and vaccines.
'A robust nationwide monitoring system is essential to quickly detect and quarantine affected animals and implement preventive measures to curb further spread and human infections,' said Elyse Stachler, GVN member and a research scientist at the Broad Institute of MIT and Harvard. 'Further, we believe it is crucial to maintain trust and stakeholder buy-in for monitoring programs, particularly from farmworkers.'
'We are advocating for community-driven strategies to ensure the successful implementation of vaccines, if necessary,' said Dr. Christian Bréchot, president emeritus of the GVN and director of the USF Health Microbiomes Institute and senior associate dean for research in global affairs in the USF Health Morsani College of Medicine. 'The situation with H5N1 demands heightened vigilance and collaboration across public health sectors. Early detection and robust surveillance are critical to prevent further spread.'
More on infectious disease:
At this rate, measles could become endemic again within 2 decades, researchers warn
As measles spreads throughout the U.S., here's how to tell if you need a booster shot
What are the symptoms of bird flu and how does it spread?
This story was originally featured on Fortune.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
36 minutes ago
- Yahoo
H5N1 bird flu ‘capable of airborne transmission'
H5N1 bird flu is capable of spreading through the air, a new animal study from the US Centres for Disease Control (CDC) has found. H5N1 was believed to spread primarily through direct contact with infected animals or their bodily fluids, but the new findings suggest it can also be transmitted through respiratory droplets and aerosol, raising concerns about its ability to cause a future pandemic. The study, published in Emerging Infectious Diseases, was based on a sample of H5N1 extracted from a dairy worker in Michigan who contracted the virus last year. The CDC scientists then used this sample to infect a group of ferrets, which are considered a 'gold standard' in flu research due to the similarity between their respiratory system and that of human. The infected animals were placed in close proximity to six other healthy ferrets and observed for three weeks. Within 21 days, three of the previously uninfected ferrets had contracted H5N1 – without any direct physical contact – indicating that the virus can travel through the air through a 'respiratory droplet transmission model'. The researchers also collected aerosol samples from the air surrounding the ferrets, and found infectious virus and viral RNA to be present, indicating that H5N1 can, like Covid-19, be transmitted through both respiratory droplets and aerosols – smaller particles that can travel longer distances and remain suspended in the air for extended periods. Respiratory droplets, on the other hand, are larger and do not travel as far in the air, requiring closer contact with an infected person for transmission. Since 2024, at least 70 people in the US have been infected with H5N1, the majority of them workers on poultry or dairy farms where the virus was present. Bird flu has spread to more than 1,000 dairy farms across the country over the past year and is now endemic among US cattle. 'This study is important as it provides yet more evidence that the H5N1 influenza virus that is circulating in dairy cattle in the USA is, in principle, capable of respiratory transmission,' Prof Ed Hutchinson, Professor of Molecular and Cellular Virology, MRC-University of Glasgow Centre for Virus Research told The Telegraph. '[The study] does this using experimental animals that experience and transmit influenza in similar ways to humans, so it warns us of what the virus could do in humans under the right circumstances,' Prof Hutchinson added. The study's authors warned that their findings underline the 'ongoing threat to public health' H5N1 poses, emphasising the need for 'continual surveillance and risk assessment… to prepare for the next influenza pandemic'. Most human cases reported in the US so far have resulted from direct physical contact with sick animals or their fluids, including cow's milk. But experts have warned that, as H5N1 continues to infect animal populations and 'jump' to humans, it is only a matter of time before the virus undergoes the mutations necessary to spread effectively from person to person. 'Because avian H5N1 viruses cross the species barrier and adapt to dairy cattle, each associated human infection presents further opportunity for mammal adaptation,' the study's authors said. Protect yourself and your family by learning more about Global Health Security Broaden your horizons with award-winning British journalism. Try The Telegraph free for 1 month with unlimited access to our award-winning website, exclusive app, money-saving offers and more.
Yahoo
an hour ago
- Yahoo
Why Trump turned against ‘gold standard' mRNA vaccines
President Trump's administration has slammed the brakes on development of messenger RNA (mRNA) vaccines, which proved their lifesaving potential during the COVID-19 pandemic but have come under increasing scrutiny among skeptics of mainstream science. The vaccines marked a breakthrough in medical technology, drastically reducing the timeline for development of targeted vaccines and even showing promise in cancer research. Trump called mRNA the 'gold standard' when he rolled out the first COVID-19 vaccines. But now they are under assault by Trump's Health and Human Services (HHS) secretary, longtime anti-vaccine advocate Robert F. Kennedy Jr., and his allies in the 'make America healthy again' movement. HHS in late May canceled $766 million awarded to Moderna through the Biomedical Advanced Research and Development Authority (BARDA) to develop a potential mRNA vaccine for bird flu. HHS spokesperson Andrew Nixon said of the decision, 'This is not simply about efficacy — it's about safety, integrity, and trust.' 'The reality is that mRNA technology remains under-tested, and we are not going to spend taxpayer dollars repeating the mistakes of the last administration, which concealed legitimate safety concerns from the public,' he added. Unlike traditional vaccines that contain fragments or weakened versions of a virus, mRNA vaccines send messenger ribonucleic acid into cells to teach the immune system to recognize proteins connected to virus cells. According to Joseph Varon, president and chief medical officer of the Independent Medical Alliance (IMA), the concerns for mRNA vaccine skeptics are the expedited timeline and conditions in which the COVID-19 vaccine was approved. 'The biggest concern is that this rushed treatment still remains in use, even under an Emergency Use Authorization in some cases. It needs to be sent back through proper studies and vetting,' Varon told The Hill. 'There needs to be an established database of vaccine injuries that can be accurately quantified with full transparency, without politics or big money pressure influencing the data,' he added. 'There's a growing body of peer-reviewed studies that indicate the spike proteins are causing havoc in certain recipients.' The IMA, previously known as Front Line COVID-19 Critical Care Alliance, launched a campaign in support of Kennedy's nomination to be HHS secretary. The group drew controversy when its founders promoted ivermectin as a 'miracle drug' for COVID-19. Myocarditis, or inflammation of the heart muscle, is of particular concern among mRNA vaccine opponents. An analysis published in 2022 found that myocarditis occurred in about 31.2 cases per 1 million second doses of the Moderna COVID-19 vaccine, or 0.003 percent. Rates of myocarditis are significantly higher among people with COVID-19 infections than immunizations, however. The development of the COVID-19 mRNA vaccine was aided by the Trump administration's Operation Warp Speed, something Trump has boasted about at numerous points. In remarks in December 2020, the same month the first COVID-19 vaccines were deployed, Trump praised Operation Warp Speed's ability to develop a SARS-CoV-2 vaccine at a 'breakneck speed,' adding 'the gold standard vaccine has been done in less than nine months.' Though research on mRNA and its potential uses has been ongoing for decades, use of the vaccines in humans is relatively new. The first mRNA vaccine candidate tested in humans was for rabies in 2013, but it wouldn't be until the COVID-19 pandemic in 2020 that this technology would achieve commercial viability and widespread use. To Kennedy, this is too much of a coincidence. In his book 'The Wuhan Cover-Up: And the Terrifying Bioweapons Arms Race,' published in 2023, Kennedy suggests it was more than just happenstance that allowed for the deployment of Moderna's mRNA technology to coincide with the global pandemic. He pointed to a meeting attended by Dr. Anthony Fauci and former BARDA Director Rick Bright in which the officials met with virologists months before the COVID-19 pandemic broke out. The fact that attendees discussed the need for innovation in influenza research and vaccines became a point of conspiracy online. Kennedy noted that Bright called for something 'completely disruptive, that's not beholden to bureaucratic strings and processes,' writing, '[Bright] hinted that only a global crisis — like a pandemic — could induce government and industry to commit the billions of dollars necessary to create a new generation of 'plug-and-play' mRNA vaccines.' In the conversation Kennedy references, Bright was discussing the challenges of making influenza research 'sexy' for Ph.D. and postdoctoral students, surmising that something 'completely disruptive' would be needed to incite excitement in the field. Proponents of the mRNA technology point to its deployment in the COVID-19 pandemic and its role in reducing transmission as evidence of safety and efficacy. 'In the U.S., you know, we have a lot of real-world experience now with huge numbers of doses given. We have been following for significant or serious adverse events for a long time, and the rate of those serious adverse events is on par with what we see for other vaccines,' E. John Wherry, director of the Institute for Immunology and Immune Health at the University of Pennsylvania, said of mRNA vaccines. As Wherry notes, all vaccines have adverse side effects, but their safety compared with the diseases they inoculate against is 'incontrovertible.' And while critics take issue with the speed at which mRNA vaccines are developed, Wherry said this difference is precisely what sets these shots apart from older generations. 'mRNA vaccines have a couple of key benefits or features that really stand out compared to other vaccine platforms. One, they can be generated very, very quickly. So, you can adapt to changes very rapidly. This is much easier with an mRNA vaccine, where the COVID strain or flu strain mutates and changes from year to year,' Wherry said. 'The second is that it's relatively simple. So, we don't have to worry about, you know, impurities in, you know, an egg-grown vaccine or a cell-based grown vaccine synthesizing mRNA. There are very few components that go into it, and it can be synthesized with high purity.' Such mRNA vaccines are also potentially applicable for numerous conditions or even multiple different strains of the same virus, giving it more flexibility than traditional vaccinations. 'So, there are substantial benefits in flexibility, in speed, in simplicity of manufacturing and that probably also affects the cost of goods at the end of the day, which is perhaps a last advantage,' Wherry added. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
3 hours ago
- Yahoo
Grand Forks Public Schools to create mental health director position
Jun. 9—GRAND FORKS — Grand Forks Public Schools plans to create a new director-level mental health position in order to meet growing needs in the district. The creation of the new behavioral health and wellness director comes after the resignation of the district's mental health coordinator. Whenever a position is vacated, district officials consider whether there's a way to restructure the position to better serve students. In this instance, "there was a loud cry from a variety of people to actually elevate the position," Associate Superintendent Catherine Gillach said. "You've heard over the course of the years some of the cries from our classroom teachers and even our special education staff themselves for help when the needs of the students might exceed what our capacity is," Gillach said, addressing the Grand Forks School Board at its regular meeting on Monday. "So really, we're looking to put this whole portfolio underneath the umbrella of somebody who has a high level of expertise and would be able to make directions and directives and that sort of thing." The creation of the position is in alignment with the district's strategic plan, which heavily emphasizes student mental health and wellness, especially since the COVID-19 pandemic, Gillach noted. The new director's job duties would include recruiting, hiring and training mental health staff, establishing partnerships with community-based organizations, planning for and executing crisis response efforts, grant procurement and management, co-leading Medicaid billing efforts and more, according to minutes from the June 2 meeting of the district Finance Committee, where the position was first proposed. The director is tentatively expected to be paid $108,669, a $13,400 increase over the existing mental health coordinator position. The final number may increase based on the final candidate's experience. In other news, the board: * Recommended the district adopt Nike as the exclusive brand represented by district athletic programs with BSN Sports as the district's exclusive supplier of athletic apparel. BSN Sports was selected over a bid from GameOne for the values of incentives it offered in its bid, its ability to comply with the district's requirements and its experience with the district. The agreement with the district will have a term of five years. Previously, teams within the district independently purchased athletic apparel. By contracting with one distributor, the district hopes to find efficiencies. * Approved a Finance Committee recommendation to establish a building fund ending balance of $1.62 million for fiscal year 2026. The board also heard an update from Brandon Baumbach on behalf of the Finance Committee that the committee reaffirmed its commitment to providing busing from the Red River and Central campuses to the Career Impact Academy. * Heard an update on the district's child nutrition program from Wendie Mankie, director of child nutrition. About 7,600 students districtwide eat school breakfast and lunch, up from last year. In the 2024-2025 school year, students ate 381,811 school breakfasts, up from 380,279 in 2023-2024 and 372,890 in 2017-2018. In 24-25, students ate 890,264 school lunches, compared with 887,426 in 23-24 and 944,256 in 17-18. Last school year, 38% of students were eligible for free and reduced price meals, compared to 34% in 23-24 and 35% in 22-23. As of May 27, there was a minus-$84,439.91 negative balance of meal accounts, down from minus-$14.65 in the 2021-2022 school year. In the coming years, Director of Child Nutrition Wendy Mankie hopes to increase meal participation at breakfast and lunch, increase the amount of from-scratch cooking in the school kitchens, implement a meal repack program and incorporate more farm-to-school items in the menus. * Accepted the resignation of Cassaundra Riewer, associate principal of Lake Agassiz Elementary. Riewer has worked at Lake Agassiz for 12 years. * Formally appointed Amber Basting as Valley Middle School's new associate principal. Basting has been a special education coordinator for Grand Forks Central and Red River high schools for three years, and recently became head of the district's Social Academic Intervention Learning (SAIL) Center. She has a total 14 years of professional experience in education. She will be paid $100,568 annually. * Renewed the memorandum of agreement with the city and the Grand Forks Police Department for School Resource Officer services for the upcoming school year. The MOA allows SROs in all in-town middle and high schools, and will be largely the same as previous school years, except for an increase of $3,641.68 in the contracted amount. The school district pays for half of the SRO program for a total cost to the district of $208,006.75 next school year. * Approved a Consolidated Grant Application for federal Title funding for the district. The district is applying for nearly $2.83 million in federal funding through Title I, a decrease of nearly $221,000 since last year. Allocations for Title II, III and IV have not yet been determined, but total Title funding for the district for the 2024-2025 school year was roughly $4.208 million. * Heard an update from the School Board Self-Assessment Committee. The board will consider future changes to how public comment portions of the meetings are structured. According to current board policy, the board does not respond to public comments made at board meetings. One option floated for future consideration is to have the board present a regular report on how the district internally responded to and handled comments. * Pending the receipt of additional quotes, the board accepted a bid from Liberty Mutual, its current provider, for property insurance. * Renewed Community High School's current lease through June 1, 2026, for an annual cost of $173,700. * Recommended Crary Real Estate as the seller of the house constructed by Ben Moen and his students during the 2024-2025 school year. Crary will earn a 5% commission on the sale. * Recommended contract negotiations with the Grand Forks Directors' Association and Grand Forks Principals' Association be extended past the July 1 deadline. Because of scheduling conflicts, negotiators have not been able to complete negotiations.
